Latest Breaking News On - Yin weidong - Page 40 : comparemela.com

China has approved emergency use of Sinovac Biotech s Covid-19 vaccine in people aged between three and 17, its chairman Yin Weidong told state TV late on Friday. Asia   Sinovac China s mass vaccination drive, which administered 723.5 million doses of vaccines as of June 3, is currently only open to those aged 18 and above. When Sinovac s vaccine will be offered to younger groups depends on health authorities formulating China s inoculation strategies, Yin told state TV in a live interview. Yin said minors have lower priority for vaccination against the coronavirus compared with the elderly, who face higher risk of severe symptoms after infection. Preliminary results from Phase I and II clinical trials showed the vaccine could trigger immune response in three to 17 year-old participants, and most adverse reactions were mild.

Sinovac biotechYin weidong